shiseido future lx total radiance foundation e neutral 3

Generic: octinoxate

Labeler: shiseido americas corporation
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name shiseido future lx total radiance foundation e neutral 3
Generic Name octinoxate
Labeler shiseido americas corporation
Dosage Form CREAM
Routes
TOPICAL
Active Ingredients

octinoxate 1832 mg/30mL

Manufacturer
SHISEIDO AMERICAS CORPORATION

Identifiers & Regulatory

Product NDC 58411-335
Product ID 58411-335_47aac3f6-8b7d-10fb-e063-6394a90aafa0
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M020
Listing Expiration 2027-12-31
Marketing Start 2017-08-01

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 58411335
Hyphenated Format 58411-335

Supplemental Identifiers

UNII
4Y5P7MUD51

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name shiseido future lx total radiance foundation e neutral 3 (source: ndc)
Generic Name octinoxate (source: ndc)
Application Number M020 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 1832 mg/30mL
source: ndc
Packaging
  • 1 JAR in 1 CARTON (58411-335-50) / 30 mL in 1 JAR
source: ndc

Packages (1)

58411-335-50 1 JAR in 1 CARTON (58411-335-50) / 30 mL in 1 JAR

Ingredients (1)

octinoxate (1832 mg/30mL)

Linked Drug Pages (1)

SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Golden 1, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Golden 2, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Golden 3, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Golden 4, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Neutral 1, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Neutral 2, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Neutral 3, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Neutral 4, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Rose 2, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Rose 3, SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Rose 4 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "47aac3f6-8b7d-10fb-e063-6394a90aafa0", "openfda": {"unii": ["4Y5P7MUD51"], "spl_set_id": ["8a9294c2-3933-4f9c-b7e6-1f446f441a16"], "manufacturer_name": ["SHISEIDO AMERICAS CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 JAR in 1 CARTON (58411-335-50)  / 30 mL in 1 JAR", "package_ndc": "58411-335-50", "marketing_start_date": "20170801"}], "brand_name": "SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Neutral 3", "product_id": "58411-335_47aac3f6-8b7d-10fb-e063-6394a90aafa0", "dosage_form": "CREAM", "product_ndc": "58411-335", "generic_name": "OCTINOXATE", "labeler_name": "SHISEIDO AMERICAS CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E", "brand_name_suffix": "Neutral 3", "active_ingredients": [{"name": "OCTINOXATE", "strength": "1832 mg/30mL"}], "application_number": "M020", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20170801", "listing_expiration_date": "20271231"}